| 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) (NCT06896188) | Anwaar Saeed | 2025-09-22 |
| Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets (NCT07278349) | Humanis Saglık Anonim Sirketi | 2025-09-21 |
| A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects (NCT07102251) | Sunshine Lake Pharma Co., Ltd. | 2025-09-21 |
| A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes (NCT07203599) | Shenzhen People's Hospital | 2025-09-20 |
| Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults (NCT07060209) | Haiphong University of Medicine and Pharmacy | 2025-09-20 |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction (NCT07166380) | Neurodawn Pharmaceutical Co., Ltd. | 2025-09-20 |
| Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions (NCT07032558) | Haiphong University of Medicine and Pharmacy | 2025-09-20 |
| Effect of Rosmarinus Officinalis Extract on Oxidative Stress and Inflammatory Biomarkers in Patients With Type 2 Diabetes(T2DM) (NCT07541729) | Universidad Autonoma de Zacatecas | 2025-09-20 |
| A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015) (NCT07025551) | Merck Sharp & Dohme LLC | 2025-09-19 |
| An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related Leukodystrophy (NCT07222371) | University of California, San Diego | 2025-09-19 |
| Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) (NCT07011654) | M.D. Anderson Cancer Center | 2025-09-19 |
| A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors (NCT07126665) | Minghui Pharmaceutical (Hangzhou) Ltd | 2025-09-18 |
| A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment (NCT07165015) | Eli Lilly and Company | 2025-09-18 |
| Phase 1 Study of SL-325 in Healthy Volunteers (NCT07158437) | Shattuck Labs, Inc. | 2025-09-18 |
| A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144 (NCT07198035) | Pfizer | 2025-09-18 |
| A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult (NCT07199270) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2025-09-18 |
| Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies (NCT07098299) | Barbara Ann Karmanos Cancer Institute | 2025-09-18 |
| A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours (NCT06682780) | LaNova Medicines Limited | 2025-09-17 |
| A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006) (NCT07334886) | Merck Sharp & Dohme LLC | 2025-09-17 |
| A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers (NCT07128654) | Celltrion | 2025-09-17 |
| Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD) (NCT06989957) | Johns Hopkins University | 2025-09-17 |
| Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects (NCT07200986) | Celltrion | 2025-09-17 |
| Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations (NCT07134998) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-16 |
| A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment (NCT07104162) | Qpex Biopharma, Inc. | 2025-09-16 |
| PVEK Corneal Implant For Treatment of Corneal Edema (NCT07325097) | Precise Bio | 2025-09-16 |
| First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics (NCT07169318) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-16 |
| Inhaled Ciclesonide Study in Preterm Infants (NCT06589245) | Venkatesh Sampath | 2025-09-16 |
| Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) (NCT07215650) | Candid Therapeutics | 2025-09-16 |
| Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow (NCT07281781) | University of California, Irvine | 2025-09-16 |
| Adding Urea to the Final Dialysis Fluid (NCT06366230) | University of California, San Francisco | 2025-09-16 |
| PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer (NCT07190469) | ProteinQure Inc. | 2025-09-16 |
| A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies (NCT07207707) | Kumquat Biosciences Inc. | 2025-09-16 |
| Epidermal Sensors for Wireless and Enhanced Amputee Skin Tracking (E-SWEAT) Part 1 (NCT07216183) | North Carolina State University | 2025-09-16 |
| A Study of Olomorasib (LY3537982) in Healthy Japanese Participants (NCT07124013) | Eli Lilly and Company | 2025-09-16 |
| A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311) (NCT07037758) | Amgen | 2025-09-16 |
| Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke (NCT07163299) | Capital Medical University | 2025-09-15 |
| A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine) (NCT06958198) | University of Oxford | 2025-09-15 |
| Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML (NCT07451912) | The First Affiliated Hospital of Soochow University | 2025-09-15 |
| Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma (NCT07072351) | West China Hospital | 2025-09-15 |
| Clinical Evaluation of Photobiomodulated Hyaluronic Acid Therapy for Interdental Papillary Loss: Minimal Invasive Blind Split Mouth Technique (NCT07012525) | Dar Al Uloom University | 2025-09-15 |
| Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer (NCT07161791) | Harbin Medical University | 2025-09-15 |
| Evaluation of Safety, Side Effects and How the Drug CHF6467 Administered Via Intranasal Route is Absorbed, Modified and Removed in Healthy Subjects (NCT07163182) | Chiesi Farmaceutici S.p.A. | 2025-09-15 |
| A Phase I Study of CREPT-618 in Locally Advanced HCC (NCT07364357) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-09-15 |
| EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) (NCT07498023) | Federal University of Latin American Integration | 2025-09-15 |
| The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis (NCT07118319) | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 2025-09-15 |
| Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants (NCT07186946) | Thryv Therapeutics, Inc. | 2025-09-15 |
| Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma (NCT07139353) | Sun Yat-sen University | 2025-09-15 |
| Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease (NCT07557706) | University of Alabama at Birmingham | 2025-09-15 |
| 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa) (NCT07155239) | Wynn Medical Center | 2025-09-15 |
| Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC) (NCT07179770) | NYU Langone Health | 2025-09-15 |
| A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors (NCT07159828) | Axion Bio, Inc | 2025-09-15 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706 (NCT06665646) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-14 |
| A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell) (NCT07338786) | Changchun BCHT Biotechnology Co. | 2025-09-13 |
| Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants (NCT07124468) | Qilu Pharmaceutical Co., Ltd. | 2025-09-13 |
| CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors (NCT07179692) | Chongqing Precision Biotech Co., Ltd | 2025-09-12 |
| A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects (NCT07210996) | Abbisko Therapeutics Co, Ltd | 2025-09-12 |
| A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications (NCT07142980) | Jiangsu HengRui Medicine Co., Ltd. | 2025-09-12 |
| A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump (NCT07152730) | Ferring Pharmaceuticals | 2025-09-12 |
| CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors (NCT07181720) | Chongqing Precision Biotech Co., Ltd | 2025-09-12 |
| A Study Evaluating 24 Months of Lithium Carbonate Treatment in Patients With TBR1-related Neurocognitive Disorder (NCT06776848) | Centre Hospitalier Universitaire Dijon | 2025-09-12 |
| Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT06824701) | University of Utah | 2025-09-12 |
| Food Effect Study in Healthy Volunteers (NCT07254286) | Biomea Fusion Inc. | 2025-09-11 |
| Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases. (NCT07144085) | Yi Tian | 2025-09-11 |
| Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects (NCT07240116) | Corcept Therapeutics | 2025-09-11 |
| Safety and Efficacy Study of CC312 for Moderate to Severe SLE (NCT07177911) | CytoCares Inc | 2025-09-11 |
| Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers (NCT07282145) | Bichedam Co., Ltd. | 2025-09-11 |
| A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection (NCT07495215) | Yinghua Xu | 2025-09-11 |
| Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection (NCT07368803) | Yifan Wang | 2025-09-11 |
| Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults (NCT05706116) | George Washington University | 2025-09-10 |
| pH1N1 Blinded Challenge Study (NCT07110532) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-10 |
| Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency (NCT04789148) | Elizabeth Austen Lawson | 2025-09-10 |
| Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults (NCT06842173) | Butantan Institute | 2025-09-10 |
| A Study of IBI3032 in Healthy Participants (NCT07120425) | Fortvita Biologics (USA)Inc. | 2025-09-10 |
| A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma (NCT06753747) | West China Hospital | 2025-09-10 |
| Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07336940) | Enveda Therapeutics | 2025-09-10 |
| CVL006 Combination Therapy in Advanced Solid Tumors (NCT07157956) | Convalife (Shanghai) Co., Ltd. | 2025-09-10 |
| Bioequivalence Study of WP205 in Healthy Subjects (NCT07158099) | Wanbangde Pharmaceutical Group Co., LTD | 2025-09-10 |
| Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers (NCT07102719) | Handok Inc. | 2025-09-10 |
| Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load (NCT06974877) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-10 |
| Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study (NCT07173374) | Shandong Cancer Hospital and Institute | 2025-09-10 |
| Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease (NCT07113743) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-10 |
| DLL3 CAR-T Therapy Targeting Brain Tumors (NCT07180927) | Shenzhen Geno-Immune Medical Institute | 2025-09-10 |
| Propranolol Treatment for Postoperative Chylothorax (NCT06833320) | June Wu | 2025-09-09 |
| Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. (NCT07363603) | Pirogov Russian National Research Medical University | 2025-09-09 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of Transdermal SFG-02 in Healthy Participants (NCT07167914) | Juro Sciences Inc. | 2025-09-09 |
| a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia (NCT07140809) | Shanghai JMT-Bio Inc. | 2025-09-09 |
| A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis (NCT07129382) | Chipscreen Biosciences, Ltd. | 2025-09-08 |
| Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer (NCT07559097) | Henan Cancer Hospital | 2025-09-08 |
| A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood (NCT07133399) | Boehringer Ingelheim | 2025-09-08 |
| PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS (NCT07761533) | Chaser Therapeutics, Inc. | 2025-09-08 |
| Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART (NCT06908083) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-09-08 |
| Drug Interaction Study on Linaprazan Glurate Capsules (NCT07294846) | Jiangsu Sinorda Biomedicine Co., Ltd | 2025-09-08 |
| Hypofractionation (Radiation) Trial for Multiple Myeloma (NCT06270888) | University of Chicago | 2025-09-08 |
| Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (NCT06814496) | University of Arizona | 2025-09-08 |
| A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions (NCT07156916) | Berlin-Chemie AG Menarini Group | 2025-09-08 |
| Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07159906) | First Affiliated Hospital of Zhejiang University | 2025-09-08 |
| Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors (NCT07348042) | Xian-Jun Yu | 2025-09-07 |
| Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 (NCT07178327) | Shanghai TTM-Bio Technology Co., Ltd | 2025-09-06 |
| A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT07288554) | Bambusa Therapeutics | 2025-09-05 |
| A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma (NCT07099430) | Nanjing Leads Biolabs Co.,Ltd | 2025-09-05 |